99% Pure / Made in USA / Multidose
CJC-1295 with Drug Affinity Complex (DAC) is a long-acting growth hormone-releasing hormone (GHRH) analog engineered for advanced research applications requiring sustained stimulation of endogenous growth hormone (GH) and downstream insulin-like growth factor-1 (IGF-1) pathways. The incorporation of DAC technology significantly extends its half-life, allowing for prolonged and stable hormonal signaling within controlled research environments.
CJC-1295 (DAC) is studied for its ability to provide continuous activation of GHRH receptors, leading to sustained GH release. Research suggests it influences:
This prolonged mechanism allows researchers to explore the effects of continuous hormone elevation on metabolic and recovery-related processes.
CJC-1295 (DAC) is widely studied for its long-acting profile. In controlled research models, it has demonstrated relevance in:
A key advantage of CJC-1295 (DAC) is its ability to support sustained endocrine activity. Research has explored its role in:
CJC-1295 (DAC) is also studied for its influence on metabolic function. Research suggests it may:
Due to its prolonged activity, CJC-1295 (DAC) is frequently utilized in recovery-focused research. Studies have examined its ability to:
For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Scroll for More >>
Made in USA
A DAC-modified peptide compound supplied for research purposes, manufactured with consistent processing and supported by batch-specific testing documentation.
$50.00
IMPORTANT: Research Use Only
By entering this website, you acknowledge that all products sold by Newbridge Peptides are intended strictly for research purposes only. They are not for human or animal consumption, medical use, or any use not permitted by applicable law.